פרופסור חלף כרידין | רפואת עור | טיפולים אסתטיים | טיפולי לייזר
Logo

כתובתנו:

רחוב ספיר 7, חיפה

התקשרו

0503772747

אימייל

prof.kridin@gmail.com

מחקרים ופרסומים מדעיים

מחקרים ופרסומים מדעיים

במשך השנים, במהלך התפתחות הקריירה המקצועית של פרופסור כרידין בתחום רפואית העור והטיפולים האסתטיים, התפרסמו מחקרים רבים שביצע בכתבי עת רפואיים נחשבים.
לפניכם רשימה חלקית של מחקרים ופרסומים מדיעיים של פרופסור כרידין:

  1. Buja A, Miatton A, Cozzolino C, Brazzale AR, Lo Bue R, Mercuri SR, Kridin K. The Prevalent Comorbidome at the Onset of Psoriasis Diagnosis. Dermatol Ther (Heidelb). 2023.
  2. Kridin K, Zirpel H, Mruwat N, Ludwig RJ, Thaci D. Evaluating the risk of infections under interleukin 23 and interleukin 17 inhibitors relative to tumour necrosis factor inhibitors – A population-based study. J Eur Acad Dermatol Venereol. 2023.
  3. Kridin K, Abou Amara Y, Barhoum M, Cohen AD. Vitiligo and systemic lupus erythematosus: A population-based study investigating the epidemiological association. J Eur Acad Dermatol Venereol. 2023.
  4. Olbrich H, Kridin K, Zirpel H, Sadik CD, Terheyden P, Thaci D, et al. Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study. EBioMedicine. 2023;93:104639.
  5. Kridin K, Ludwig RJ. Reply to comment on: "Isotretinoin and the risk of psychiatric disturbances – A global study shedding new light on a debatable story". J Am Acad Dermatol. 2023.
  6. Raap U, Limberg MM, Kridin K, Ludwig RJ. Pruritus Is Associated with an Increased Risk for the Diagnosis of Autoimmune Skin Blistering Diseases: A Propensity-Matched Global Study. Biomolecules. 2023;13(3).
  7. Antiga E, Bech R, Maglie R, Genovese G, Borradori L, Bockle B, et al. S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2023;37(6):1118-34.
  8. Kridin K, Ludwig RJ. Reply to: "Interpreting with caution the lack of association between isotretinoin, depression, and suicide". J Am Acad Dermatol. 2023.
  9. Kridin K, Vorobyev A, Papara C, De Luca DA, Bieber K, Ludwig RJ. Risk factors and sequelae of epidermolysis bullosa acquisita: A propensity-matched global study in 1,344 patients. Front Immunol. 2022;13:1103533.
  10. Kridin K, Mruwat N, Amber KT, Ludwig RJ. Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study. Br J Dermatol. 2023;188(4):499-505.
  11. Kridin K, van Beek N, Buhler E, Kochan AS, Ranjbar M, Beissert S, et al. Characteristics Associated With Refractory Course, Blindness, and Treatment Strategy-Related Outcomes in Patients With Mucous Membrane Pemphigoid. JAMA Dermatol. 2023;159(2):198-203.
  12. Damiani G, Finelli R, Kridin K, Pacifico A, Bragazzi NL, Malagoli P, et al. Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population. Eur Rev Med Pharmacol Sci. 2022;26(3 Suppl):87-93.
  13. Kridin K, Mruwat N, Thaci D, Ludwig RJ. The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large-scale global cohort study. J Eur Acad Dermatol Venereol. 2023;37(5):e683-e5.
  14. Kridin K, Ludwig RJ. Isotretinoin and the risk of inflammatory bowel disease and irritable bowel syndrome: A large-scale global study. J Am Acad Dermatol. 2023;88(4):824-30.
  15. Boch K, Langan EA, Van Beek N, Kridin K, Schmidt E, Zillikens D, et al. Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris. Acta Derm Venereol. 2022;102:adv00835.
  16. Kridin K, Bruggen MC, Walsh S, Bensaid B, Ranki A, Oppel E, et al. Management and treatment outcome of DRESS patients in Europe: An international multicentre retrospective study of 141 cases. J Eur Acad Dermatol Venereol. 2023;37(4):753-62.
  17. Kridin K, Ingram B, Becker D, Shiloah N, Azrad M, Habib S, et al. Sexually Transmitted Diseases in Northern Israel: Insights From a Large Referral Laboratory. J Low Genit Tract Dis. 2023;27(1):51-5.
  18. Kridin K, Mruwat N, Ludwig RJ. Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus. JAMA Dermatol. 2023;159(1):56-61.
  19. Bieber K, Hundt JE, Yu X, Ehlers M, Petersen F, Karsten CM, et al. Autoimmune pre-disease. Autoimmun Rev. 2023;22(2):103236.
  20. Shavit E, Cohen A, Zoller L, Onn E, Kridin K. The burden of gout in acne keloidalis nuchae-Insights from a population-based study. J Cosmet Dermatol. 2023;22(1):284-8.
  21. Anis O, Kridin K, Cohen AD, Levmore M, Yaron S, Valdman-Grinshpoun Y, et al. Chronic Spontaneous Urticaria in Patients With Interstitial Cystitis/Bladder Pain Syndrome: Insights From Big Data Analyses. Urology. 2023;171:83-7.
  22. Kridin K, Lyakhovitsky K, Tzur-Bitan D, Onn E, Lyakhovitsky A, Zoller L, et al. Vitiligo and systemic sclerosis: Are they associated?- Lessons from a population-based study. Australas J Dermatol. 2023;64(1):e65-e71.
  23. Haeger SC, Kridin K, Pieper M, Griewahn L, Nimmerjahn F, Zillikens D, et al. Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita. Front Immunol. 2022;13:938306.
  24. Boch K, Zirpel H, Thaci D, Mruwat N, Zillikens D, Ludwig RJ, et al. Mortality in eight autoimmune bullous diseases: A global large-scale retrospective cohort study. J Eur Acad Dermatol Venereol. 2023;37(4):e535-e7.
  25. Boch K, Langan EA, Zillikens D, Ludwig RJ, Kridin K. Evaluation of clinical and laboratory characteristics of patients with cutaneous sarcoidosis: A single-center retrospective cohort study. Front Med (Lausanne). 2022;9:980507.
  26. Controne I, Scoditti E, Buja A, Pacifico A, Kridin K, Fabbro MD, et al. Do Sleep Disorders and Western Diet Influence Psoriasis? A Scoping Review. Nutrients. 2022;14(20).
  27. Kridin K, Ludwig RJ. Isotretinoin and the risk of psychiatric disturbances: A global study shedding new light on a debatable story. J Am Acad Dermatol. 2023;88(2):388-94.
  28. Kridin K, Goral D, Shihade W, Tzur-Bitan D, Onn E, Zoller L, et al. Vitiligo and Crohn's disease form an autoimmune cluster: insights from a population-based study. Scand J Gastroenterol. 2023;58(4):354-9.
  29. Kridin K, Hammers CM. Atypical clinical manifestation and protracted latency are observed in the emerging variant of checkpoint inhibitor-associated bullous pemphigoid. Br J Dermatol. 2022;187(6):843-4.
  30. Damiani G, Finelli R, Kridin K, Pacifico A, Bragazzi NL, Malagoli P, et al. Facial atopic dermatitis may be exacerbated by masks: insights from a multicenter, teledermatology, prospective study during COVID-19 pandemic. Ital J Dermatol Venerol. 2022;157(6):505-9.
  31. Tzur Bitan D, Givon-Lavi N, Kridin K, Kaliner E, Krieger I, Dov Cohen A, et al. Severe breakthrough COVID-19 infections in vaccinated patients with schizophrenia in Israel. World Psychiatry. 2022;21(3):471-2.
  32. Kridin K, Schonmann Y, Onn E, Bitan DT, Weinstein O, Shavit E, et al. Nineteen months into the pandemic, what have we learned about COVID-19-related outcomes in patients with psoriasis? J Cosmet Dermatol. 2022;21(12):6549-53.
  33. Shavit E, Dagan O, Cohen AD, Valdman-Grinshpoun Y, Kridin K. Risk of cardiovascular diseases in pyoderma gangrenosum: A population-based study. J Eur Acad Dermatol Venereol. 2023;37(2):e197-e9.
  34. Bieber K, Harder M, Stander S, Boch K, Kridin K, Kohler B, et al. DNA-Chip-basierte Diagnose der Onychomykose und Tinea pedis. J Dtsch Dermatol Ges. 2022;20(8):1112-22.
  35. Kridin K, Valido K, Cohen JM, Cohen AD. Hidradenitis suppurativa and the risk of myocardial infarction, cerebrovascular accident, and peripheral vascular disease: a population-based study. Arch Dermatol Res. 2023;315(3):429-35.
  36. Hamed Azzam S, Mukari A, Hamed M, Kridin K. Influence of COVID-19 mRNA vaccination on the efficacy and safety of Botulinum toxin type A injections. J Cosmet Dermatol. 2022;21(9):3663-6.
  37. Bieber K, Harder M, Stander S, Boch K, Kridin K, Kohler B, et al. DNA chip-based diagnosis of onychomycosis and tinea pedis. J Dtsch Dermatol Ges. 2022;20(8):1112-21.
  38. Damiani G, Finelli R, Kridin K, Pacifico A, Buja A, Bragazzi NL, et al. Masks trigger facial seborrheic dermatitis and psoriasis: evidence from a multicenter, case-control study during COVID-19 pandemic. Ital J Dermatol Venerol. 2022;157(5):419-23.
  39. Weinstein O, Kridin M, Kridin K, Mann O, Cohen AD, Zloto O. The risk of retinal vein occlusion among patients with neovascular age related macular degeneration: a large-scale cohort study. Eye (Lond). 2023;37(7):1445-50.
  40. Borradori L, Van Beek N, Feliciani C, Tedbirt B, Antiga E, Bergman R, et al. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2022;36(10):1689-704.
  41. Ujiie H, Rosmarin D, Schon MP, Stander S, Boch K, Metz M, et al. Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases. Front Med (Lausanne). 2022;9:875492.
  42. Kridin K, Lyakhovitsky K, Onn E, Lyakhovitsky A, Ludwig R, Weinstein O, et al. Investigating the epidemiological relationship between vitiligo and psoriasis: a population-based study. Arch Dermatol Res. 2023;315(3):395-400.
  43. Kridin K, Hubner F, Linder R, Schmidt E. The association of six autoimmune bullous diseases with thyroid disorders: a population-based study. J Eur Acad Dermatol Venereol. 2022;36(10):1826-30.
  44. Fisher S, Kagan I, Zoller L, Cohen AD, Kridin K. Hidradenitis suppurativa: Evaluating activity patterns and predictors of recalcitrant course-A population-based study. Australas J Dermatol. 2022;63(3):321-7.
  45. Tzur Bitan D, Kridin K, Givon-Lavi N, Krieger I, Kaliner E, Cohen AD, et al. COVID-19 Booster Vaccination Among Individuals With Schizophrenia in Israel. JAMA Psychiatry. 2022;79(5):508-12.
  46. Kridin M, Zloto O, Kridin K, Cohen AD, Mann O, Weinstein O. The association of uveitis with hepatitis B and hepatitis C viruses: a large-scale population-based study. Eye (Lond). 2023;37(4):720-4.
  47. Kridin K, Schonmann Y, Onn E, Bitan DT, Weinstein O, Cohen AD. Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study. Am J Clin Dermatol. 2022;23(3):385-92.
  48. Friedland R, Kridin K, Cohen AD, Landau D, Ben-Amitai D. Psoriasis and Renal Disorders: A Large-Scale Population-Based Study in Children and Adults. Dermatology. 2022;238(5):904-9.
  49. Tzur Bitan D, Berzin D, Kridin K, Sela Y, Cohen A. Alopecia Areata as a Proximal Risk Factor for the Development of Comorbid Depression: A Population-based Study. Acta Derm Venereol. 2022;102:adv00669.
  50. Kridin K, Avni O, Damiani G, Tzur Bitan D, Onn E, Weinstein O, et al. Dipeptidyl-peptidase IV inhibitor (DPP4i) confers increased odds of bullous pemphigoid even years after drug initiation. Arch Dermatol Res. 2023;315(1):33-9.
  51. Kridin K, Schmidt E. Epidemiology of Pemphigus. JID Innov. 2021;1(1):100004.
  52. van Beek N, Kridin K, Buhler E, Kochan AS, Stander S, Ludwig RJ, et al. Evaluation of Site- and Autoantigen-Specific Characteristics of Mucous Membrane Pemphigoid. JAMA Dermatol. 2022;158(1):84-9.
  53. Boch K, Langan EA, Kridin K, Zillikens D, Ludwig RJ, Bieber K. Lichen Planus. Front Med (Lausanne). 2021;8:737813.
  54. Boch K, Langan EA, Zillikens D, Ludwig RJ, Kridin K. Retrospective analysis of the clinical characteristics and patient-reported outcomes in vulval lichen planus: Results from a single-center study. J Dermatol. 2021;48(12):1913-7.
  55. Kridin K, Schonmann Y, Solomon A, Onn E, Bitan DT, Weinstein O, et al. Risk of COVID-19 and its complications in patients with atopic dermatitis undergoing dupilumab treatment-a population-based cohort study. Immunol Res. 2022;70(1):106-13.
  56. Pacifico A, Conic RRZ, Cristaudo A, Garbarino S, Ardigo M, Morrone A, et al. Diet-Related Phototoxic Reactions in Psoriatic Patients Undergoing Phototherapy: Results from a Multicenter Prospective Study. Nutrients. 2021;13(9).
  57. Kridin K, Hammers CM, Ludwig RJ, Onn E, Schonmann Y, Abu-Elhija A, et al. The Association of Bullous Pemphigoid With Atopic Dermatitis and Allergic Rhinitis-A Population-Based Study. Dermatitis. 2022;33(4):268-76.
  58. Patel PM, Jones VA, Kridin K, Strong RA, Yale M, Amber KT. Assessing the risk factors for anxiety, depression and post-traumatic stress disorder through the International Pemphigus and Pemphigoid Foundation. J Eur Acad Dermatol Venereol. 2022;36(2):e139-e41.
  59. Stander S, Schmidt E, Zillikens D, Ludwig RJ, Kridin K. Immunologische Merkmale und Faktoren im Zusammenhang mit dem mukokutanen bullosen Pemphigoid – eine retrospektive Kohortenstudie. J Dtsch Dermatol Ges. 2021;19(9):1289-96.
  60. Ben-Shabat N, Shabat A, Watad A, Kridin K, Bragazzi NL, McGonagle D, et al. Reply. Arthritis Care Res (Hoboken). 2022;74(12):2121-2.
  61. Kridin K, Bruggen MC, Chua SL, Bygum A, Walsh S, Nageli MC, et al. Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study. JAMA Dermatol. 2021;157(10):1182-90.
  62. Kridin K, Shavit E, Damiani G, Cohen AD. Hidradenitis suppurativa and rheumatoid arthritis: evaluating the bidirectional association. Immunol Res. 2021;69(6):533-40.
  63. Kridin M, Kridin K, Cohen AD, Amital H, Watad A. The risk, predictors and outcomes of amyloidosis in ankylosing spondylitis: a longitudinal population-based cohort study. Rheumatology (Oxford). 2022;61(5):2072-8.
  64. Tzur Bitan D, Kridin K, Cohen AD, Weinstein O. COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study. Lancet Psychiatry. 2021;8(10):901-8.
  65. Emtenani S, Ghorbanalipoor S, Mayer-Hain S, Kridin K, Komorowski L, Probst C, et al. Pathogenic Activation and Therapeutic Blockage of FcalphaR-Expressing Polymorphonuclear Leukocytes in IgA Pemphigus. J Invest Dermatol. 2021;141(12):2820-8.
  66. Stander S, Schmidt E, Zillikens D, Ludwig RJ, Kridin K. Immunological features and factors associated with mucocutaneous bullous pemphigoid – a retrospective cohort study. J Dtsch Dermatol Ges. 2021;19(9):1289-95.
  67. Kridin K, Hubner F, Recke A, Linder R, Schmidt E. The burden of neurological comorbidities in six autoimmune bullous diseases: a population-based study. J Eur Acad Dermatol Venereol. 2021;35(10):2074-8.
  68. Solimani F, Didona D, Li J, Bao L, Patel PM, Gasparini G, et al. Characterizing the proteome of bullous pemphigoid blister fluid utilizing tandem mass tag labeling coupled with LC-MS/MS. Arch Dermatol Res. 2022;314(9):921-8.
  69. Kridin K, Schonmann Y, Tzur Bitan D, Damiani G, Weinstein O, Cohen AD. The Burden of Coronavirus Disease 2019 and Its Complications in Patients With Atopic Dermatitis-A Nested Case-Control Study. Dermatitis. 2021;32(1S):S45-S52.
  70. Tzur Bitan D, Berzin D, Kridin K, Cohen A. The association between alopecia areata and anxiety, depression, schizophrenia, and bipolar disorder: a population-based study. Arch Dermatol Res. 2022;314(5):463-8.
  71. Kridin K, Laufer Britva R, Tzur Bitan D, Damiani G, Cohen AD. Is pyoderma gangrenosum associated with solid malignancies? Insights from a population-based cohort study. Australas J Dermatol. 2021;62(3):336-41.
  72. Kridin K, Schonmann Y, Tzur Bitan D, Damiani G, Peretz A, Weinstein O, et al. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization and Mortality in Patients with Psoriasis: A Population-Based Study. Am J Clin Dermatol. 2021;22(5):709-18.
  73. Kridin K, Schonmann Y, Damiani G, Peretz A, Onn E, Bitan DT, et al. Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-A population-based cohort study. Dermatol Ther. 2021;34(4):e15003.
  74. Kridin K, Hammers CM, Ludwig RJ, Tzur Bitan D, Cohen AD. Survival of Adjuvant Drugs for Treatment of Pemphigus: A Population-based Cohort Study. Acta Derm Venereol. 2021;101(9):adv00535.
  75. Cohen JM, Kridin K, Perez-Chada LM, Merola JF, Cohen AD. Hepatitis B and C among patients with hidradenitis suppurativa: a population-based study. Int J Dermatol. 2022;61(1):84-8.
  76. Ben-Shabat N, Shabat A, Watad A, Kridin K, Bragazzi NL, McGonagle D, et al. Mortality in Ankylosing Spondylitis According to Treatment: A Nationwide Retrospective Cohort Study of 5,900 Patients From Israel. Arthritis Care Res (Hoboken). 2022;74(10):1614-22.
  77. Kridin K, Patel PM, Amber KT, Cohen AD. 'Hidradenitis suppurativa and amyloidosis: a possible association with the pyrin inflammasome': reply from authors. Clin Exp Dermatol. 2021;46(6):1118-9.
  78. Stander S, Hammers CM, Vorobyev A, Schmidt E, Hundt JE, Sadik CD, et al. Coexistence of bullous pemphigoid with neuropsychiatric comorbidities is associated with anti-BP230 seropositivity. J Eur Acad Dermatol Venereol. 2021;35(10):2067-73.
  79. Stander S, Hammers CM, Vorobyev A, Schmidt E, Zillikens D, Ghorbanalipoor S, et al. The impact of lesional inflammatory cellular infiltrate on the phenotype of bullous pemphigoid. J Eur Acad Dermatol Venereol. 2021;35(8):1702-11.
  80. Stander S, Ha L, Kridin K, Bieber K, Zillikens D, Ludwig RJ, et al. DNA-chip-based molecular testing as a clue for the diagnosis of tinea: a case series. J Eur Acad Dermatol Venereol. 2021;35(8):e522-e4.
  81. Cohen JM, Kridin K, Perez-Chada LM, Merola JF, Cohen AD. Hidradenitis suppurativa and sleep disorders: a population-based study. J Eur Acad Dermatol Venereol. 2021;35(8):e520-e2.
  82. Kridin K, Solomon A, Britva RL, Bitan DT, Cohen AD. Chronic renal comorbidities in pyoderma gangrenosum: a retrospective cohort study. Immunol Res. 2021;69(3):249-54.
  83. Krieger I, Grossman-Giron A, Comaneshter D, Weinstein O, Kridin K, Cohen AD, et al. The co-occurrence of autistic spectrum disorder and schizophrenia: A nationwide population-based study. J Psychiatr Res. 2021;138:280-3.
  84. Kridin K, Bieber K, Sadik CD, Schon MP, Wang G, Loser K, et al. Editorial: Skin Autoimmunity. Front Immunol. 2021;12:627565.
  85. Kridin K, Schonmann Y, Solomon A, Damiani G, Tzur Bitan D, Onn E, et al. Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors. J Dermatolog Treat. 2022;33(4):2014-20.
  86. Kridin K, Schonmann Y, Weinstein O, Schmidt E, Ludwig RJ, Cohen AD. The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study. J Am Acad Dermatol. 2021;85(1):79-87.
  87. Pam N, Kridin K, Khamaysi Z. Propranolol for infantile hemangioma: Evaluating efficacy and predictors of response and rebound growth. Dermatol Ther. 2021;34(3):e14936.
  88. Kridin K, Hundt JE, Ludwig RJ, Amber KT, Bitan DT, Cohen AD. Melanoma is associated with an increased risk of bullous pemphigoid: a large population-based longitudinal study. Arch Dermatol Res. 2022;314(1):77-83.
  89. Kridin K, Cohen AD. The underestimated risk for complications in immunocompetent patients with herpes zoster: should we change our clinical practice? Br J Dermatol. 2021;184(6):994-5.
  90. Kridin K, Damiani G, Ludwig RJ, Tzur Bitan D, Cohen AD. Estimating the Odds of Ulcerative Colitis-Associated Pyoderma Gangrenosum: A Population-Based Case-Control Study. Dermatology. 2021;237(3):323-9.
  91. Kridin K, Ludwig RJ, Tzur Bitan D, Cohen AD. A History of Asthma Increases the Risk of Bullous Pemphigoid: Insights from a Large Population-Based Study. Dermatology. 2021;237(6):921-8.
  92. Bragazzi NL, Trabelsi K, Garbarino S, Ammar A, Chtourou H, Pacifico A, et al. Can intermittent, time-restricted circadian fasting modulate cutaneous severity of dermatological disorders? Insights from a multicenter, observational, prospective study. Dermatol Ther. 2021;34(3):e14912.
  93. Tzur Bitan D, Krieger I, Kridin K, Komantscher D, Scheinman Y, Weinstein O, et al. COVID-19 Prevalence and Mortality Among Schizophrenia Patients: A Large-Scale Retrospective Cohort Study. Schizophr Bull. 2021;47(5):1211-7.
  94. Damiani G, Gironi LC, Grada A, Kridin K, Finelli R, Buja A, et al. COVID-19 related masks increase severity of both acne (maskne) and rosacea (mask rosacea): Multi-center, real-life, telemedical, and observational prospective study. Dermatol Ther. 2021;34(2):e14848.
  95. Damiani G, Gironi LC, Kridin K, Pacifico A, Buja A, Bragazzi NL, et al. Mask-induced Koebner phenomenon and its clinical phenotypes: A multicenter, real-life study focusing on 873 dermatological consultations during COVID-19 pandemics. Dermatol Ther. 2021;34(2):e14823.
  96. Bieber K, Kridin K, Emtenani S, Boch K, Schmidt E, Ludwig RJ. Milestones in Personalized Medicine in Pemphigus and Pemphigoid. Front Immunol. 2020;11:591971.
  97. Kridin K, Ahmed AR. The evolving role of rituximab in the treatment of pemphigus vulgaris: a comprehensive state-of-the-art review. Expert Opin Biol Ther. 2021;21(4):443-54.
  98. Tzur Bitan D, Kridin K, Hodak E, Cohen A, Sherman S. The association between hidradenitis suppurativa and male and female infertility: A population-based study. Australas J Dermatol. 2021;62(2):e223-e7.
  99. Sherman S, Kridin K, Bitan DT, Leshem YA, Hodak E, Cohen AD. Hidradenitis suppurativa and atopic dermatitis: A 2-way association. J Am Acad Dermatol. 2021;85(6):1473-9.
  100. Kridin K, Hammers CM, Ludwig RJ, Cohen AD. Risk of solid malignancies in bullous pemphigoid: A large-scale population-based cohort study. J Dermatol. 2021;48(3):317-23.
  101. Valdman-Grinshpoun Y, Kridin K, Schonmann Y, Cohen AD. Acne keloidalis nuchae and thyroid diseases: a population-based cohort study. Int J Dermatol. 2021;60(4):466-70.
  102. Yaccob A, Kridin K, Mari A, Fagoonee S. Cutaneous involvement of hepatitis C virus. Which future after new antiviral drugs? G Ital Dermatol Venereol. 2020;155(5):599-601.
  103. Stander S, Holtsche MM, Schmidt E, Hammers CM, Zillikens D, Ludwig RJ, et al. Presence of Cutaneous Complement Deposition Distinguishes between Immunological and Histological Features of Bullous Pemphigoid-Insights from a Retrospective Cohort Study. J Clin Med. 2020;9(12).
  104. Sherman S, Tzur Bitan D, Kridin K, Pavlovsky L, Hodak E, Cohen AD. Hidradenitis suppurativa is associated with hypothyroidism and hyperthyroidism: a large-scale population-based study. Int J Dermatol. 2021;60(3):321-6.
  105. Kridin K, Jones VA, Patel PM, Zelber-Sagi S, Hammers CM, Damiani G, et al. Patients with pemphigus are at an increased risk of developing rheumatoid arthritis: a large-scale cohort study. Immunol Res. 2020;68(6):373-8.
  106. Patel PM, Jones VA, Kridin K, Amber KT. The role of Dipeptidyl Peptidase-4 in cutaneous disease. Exp Dermatol. 2021;30(3):304-18.
  107. Stander S, Schmidt E, Zillikens D, Thaci D, Ludwig RJ, Kridin K. Patients with bullous pemphigoid and comorbid psoriasis present with less blisters and lower serum levels of anti-BP180 autoantibodies. J Eur Acad Dermatol Venereol. 2021;35(4):981-7.
  108. Damiani G, Kridin K, Pacifico A, Malagoli P, Pigatto PDM, Finelli R, et al. Antihistamines-refractory chronic pruritus in psoriatic patients undergoing biologics: aprepitant vs antihistamine double dosage, a real-world data. J Dermatolog Treat. 2022;33(3):1554-7.
  109. Kridin K, Kridin M, Amital H, Watad A, Khamaisi M. Mortality in Patients with Polymyositis and Dermatomyositis in an Israeli Population. Isr Med Assoc J. 2020;22(10):623-7.
  110. Stander S, Schmidt E, Zillikens D, Ludwig RJ, Kridin K. More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort Study. Am J Clin Dermatol. 2021;22(1):117-27.
  111. Kridin K, Ludwig RJ, Schonmann Y, Damiani G, Cohen AD. The Bidirectional Association Between Bullous Pemphigoid and Psoriasis: A Population-Based Cohort Study. Front Med (Lausanne). 2020;7:511.
  112. Burmester IAK, Flaswinkel S, Thies CS, Kasprick A, Kamaguchi M, Bumiller-Bini V, et al. Identification of novel therapeutic targets for blocking acantholysis in pemphigus. Br J Pharmacol. 2020;177(22):5114-30.
  113. Kridin K, Solomon A, Tzur-Bitan D, Damiani G, Comaneshter D, Cohen AD. Acne Keloidalis Nuchae and the Metabolic Syndrome: A Population-Based Study. Am J Clin Dermatol. 2020;21(5):733-9.
  114. Kridin K, Ludwig RJ, Damiani G, Cohen AD. Increased Risk of Pemphigus among Patients with Psoriasis: A Large-scale Cohort Study. Acta Derm Venereol. 2020;100(17):adv00293.
  115. Kridin K, Linder D, Shalom G, Piaserico S, Babaev M, Freud T, et al. Psoriasis and Dementia: A Cross-sectional Study of 121,801 Patients. Acta Derm Venereol. 2020;100(15):adv00250.
  116. Kridin K, Patel PM, Jones VA, Damiani G, Amber KT, Cohen AD. Hidradenitis suppurativa is associated with acne keloidalis nuchae: a population-based study. Arch Dermatol Res. 2021;313(5):333-7.
  117. Kridin K, Damiani G, Ludwig RJ, Tzur-Bitan D, Cohen AD. Quantification of the relationship between pyoderma gangrenosum and Crohn's disease: a population-based case-control study. Scand J Gastroenterol. 2020;55(7):814-8.
  118. Kridin K, Damiani G, Cohen AD. Rheumatoid arthritis and pyoderma gangrenosum: a population-based case-control study. Clin Rheumatol. 2021;40(2):521-8.
  119. Kridin K, Vanetik S, Damiani G, Cohen AD. Big data highlights the association between psoriasis and fibromyalgia: a population-based study. Immunol Res. 2020;68(3):135-40.
  120. Kridin K. Dipeptidyl-peptidase IV inhibitors (DPP4i)-associated bullous pemphigoid: Estimating the clinical profile and exploring intraclass differences. Dermatol Ther. 2020;33(4):e13790.
  121. Kridin K, Ludwig RJ, Tzur Bitan D, Kridin M, Damiani G, Cohen AD. Is Gout Associated with Pyoderma Gangrenosum? A Population-Based Case-Control Study. J Clin Med. 2020;9(6).
  122. Bragazzi NL, Ricco M, Pacifico A, Malagoli P, Kridin K, Pigatto P, et al. COVID-19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED-ZONE declaration. Dermatol Ther. 2020;33(4):e13508.
  123. Laufer Britva R, Kridin M, Kridin K. Red Blood Cell Distribution Width Is Increased in Patients with Pemphigus: A Case-Control Study. Ann Clin Lab Sci. 2020;50(2):253-9.
  124. Kridin K, Wollner M, Bergman R. Inflammatory changes in actinic keratoses associated with afatinib therapy. Cutis. 2020;105(3):E16-E8.
  125. Kridin K, Cohen AD. Anti-psoriatic therapies and cardiovascular risk: is there a difference between different systemic agents? J Eur Acad Dermatol Venereol. 2020;34(4):668-9.
  126. Kridin K, Pam N, Bergman R, Khamaysi Z. Oral propranolol administration is effective for infantile hemangioma in late infancy: A retrospective cohort study. Dermatol Ther. 2020;33(3):e13331.
  127. Kridin K, Renert-Yuval Y, Guttman-Yassky E, Cohen AD. Alopecia Areata Is Associated with Atopic Diathesis: Results from a Population-Based Study of 51,561 Patients. J Allergy Clin Immunol Pract. 2020;8(4):1323-8 e1.
  128. Kridin K, Jones VA, Patel PM, Gibson FT, Amber KT, Cohen AD. Hidradenitis suppurativa and pemphigus: a cross-sectional study. Arch Dermatol Res. 2020;312(7):501-5.
  129. Kridin K, Amber KT, Comaneshter D, Cohen AD. Amyloidosis in hidradenitis suppurativa: a cross-sectional study and review of the literature. Clin Exp Dermatol. 2020;45(5):565-71.
  130. Kridin K, Shalom G, Comaneshter D, Cohen AD. Is there an association between alopecia areata and systemic lupus erythematosus? A population-based study. Immunol Res. 2020;68(1):1-6.
  131. Kridin K, Ahmed AR. Post-rituximab immunoglobulin M (IgM) hypogammaglobulinemia. Autoimmun Rev. 2020;19(3):102466.
  132. Kridin K, Cohen AD. Hidradenitis suppurativa and infections. Br J Dermatol. 2020;182(2):267.
  133. Einy S, Ben-Barak A, Kridin K, Aizenbud D. Craniofacial Deformities in Patients With Beta-Thalassemia: Orthodontic Versus Surgical Correction-A Systematic Review. J Pediatr Hematol Oncol. 2020;42(3):198-203.
  134. Kridin K, Patel PM, Jones VA, Cordova A, Amber KT. IgA pemphigus: A systematic review. J Am Acad Dermatol. 2020;82(6):1386-92.
  135. Kridin K, Tzur Bitan D, Comaneshter D, Cohen AD. The prevalence of systemic sclerosis is increased among patients with alopecia areata: a population-based study. Immunol Res. 2019;67(4-5):368-72.
  136. Shalom G, Kridin K, Cohen AD. Clinical criteria and sensitivity – what should be preferred when we tackle highly conflicting issues Response to 'Metabolic syndrome and atopic dermatitis: reconsidering the definition criteria'. J Eur Acad Dermatol Venereol. 2020;34(3):e131.
  137. Kridin K, Ahmed AR. Anti-p200 Pemphigoid: A Systematic Review. Front Immunol. 2019;10:2466.
  138. Shalom G, Kridin K, Raviv KO, Freud T, Comaneshter D, Friedland R, et al. Atopic Dermatitis and Celiac Disease: A Cross-Sectional Study of 116,816 Patients. Am J Clin Dermatol. 2020;21(1):133-8.
  139. Laufer Britva R, Amber KT, Cohen AD, Kridin K. Treatment and clinical outcomes in anti-p200 pemphigoid: a systematic review. J Eur Acad Dermatol Venereol. 2020;34(3):465-72.
  140. Einy S, Kridin K, Kaufman AY, Cohenca N. Immediate post-operative rehabilitation after decoronation. A systematic review. Dent Traumatol. 2020;36(2):141-50.
  141. Kridin K, Kridin M, Amber KT, Shalom G, Comaneshter D, Batat E, et al. The Risk of Pulmonary Embolism in Patients With Pemphigus: A Population-Based Large-Scale Longitudinal Study. Front Immunol. 2019;10:1559.
  142. Kridin K, Kowalski EH, Kneiber D, Laufer-Britva R, Amber KT. From bench to bedside: evolving therapeutic targets in autoimmune blistering disease. J Eur Acad Dermatol Venereol. 2019;33(12):2239-52.
  143. Kowalski EH, Kneibner D, Patel A, Kridin K, Amber KT. Evaluation of serum cytokine and chemokine levels in dermatitis herpetiformis: a systematic review and meta-analysis. Immunol Res. 2019;67(2-3):265-6.
  144. Kridin K, Kneiber D, Kowalski EH, Valdebran M, Amber KT. Epidermolysis bullosa acquisita: A comprehensive review. Autoimmun Rev. 2019;18(8):786-95.
  145. Kneiber D, Kowalski EH, Kridin K, Yale ML, Grando SA, Amber KT. Gastrointestinal symptoms, gastrointestinal bleeding and the role of diet in patients with autoimmune blistering disease: a survey of the International Pemphigus and Pemphigoid Foundation. J Eur Acad Dermatol Venereol. 2019;33(10):1935-40.
  146. Shalom G, Dreiher J, Kridin K, Horev A, Khoury R, Battat E, et al. Atopic dermatitis and the metabolic syndrome: a cross-sectional study of 116 816 patients. J Eur Acad Dermatol Venereol. 2019;33(9):1762-7.
  147. Kridin K, Zelber-Sagi S, Kridin M, Cohen AD. Bullous pemphigoid and neuropsychiatric medications: An influence of drugs or of underlying conditions? J Am Acad Dermatol. 2023;88(3):e137.
  148. Kneiber D, Kowalski EH, Kridin K, Amber KT. Pemphigus subtype: a confounder in determining the association of oral involvement with post-rituximab relapses. Dermatol Ther. 2019;32(3):e12918.
  149. Kowalski EH, Kneiber D, Kridin K, Amber KT. Comment on "Incidence of pneumocystosis among patients exposed to immunosuppression". J Am Acad Dermatol. 2019;81(2):e47.
  150. Kridin K, Ahn C, Huang WC, Ansari A, Sami N. Treatment Update of Autoimmune Blistering Diseases. Dermatol Clin. 2019;37(2):215-28.
  151. Kowalski EH, Kneibner D, Kridin K, Amber KT. Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid. Autoimmun Rev. 2019;18(5):526-34.
  152. Shalom G, Babaev M, Kridin K, Schonmann Y, Horev A, Dreiher J, et al. Healthcare Service Utilization by 116,816 Patients with Atopic Dermatitis in Israel. Acta Derm Venereol. 2019;99(4):370-4.
  153. Kridin K, Laufer-Britva R, Kridin M, Comaneshter D, Batat E, Cohen AD. The relationship between pemphigus and systemic lupus erythematosus: a cross-sectional study, systematic review, and meta-analysis. Immunol Res. 2019;67(1):116-22.
  154. Kridin K, Bergman R. Assessment of the Prevalence of Mucosal Involvement in Bullous Pemphigoid. JAMA Dermatol. 2019;155(2):166-71.
  155. Shalom G, Kridin K, Babaev M, Magen E, Tiosano S, Dreiher J, et al. Chronic urticaria and osteoporosis: a longitudinal, community-based cohort study of 11 944 patients. Br J Dermatol. 2019;180(5):1077-82.
  156. Kridin K, Shani M, Schonmann Y, Fisher S, Shalom G, Comaneshter D, et al. Psoriasis and hidradenitis suppurativa: A large-scale population-based study. J Am Acad Dermatol. 2023;88(5):e231-e6.
  157. Kridin K. Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study". J Am Acad Dermatol. 2018;79(6):e111-e2.
  158. Kridin K, Bergman R. The Usefulness of Indirect Immunofluorescence in Pemphigus and the Natural History of Patients With Initial False-Positive Results: A Retrospective Cohort Study. Front Med (Lausanne). 2018;5:266.
  159. Kridin K, Kridin M, Shalom G, Cohen AD. The coexistence of pemphigus and psoriasis: a systematic review and meta-analysis. Immunol Res. 2019;67(1):134-41.
  160. Kridin K, Cohen AD. Dipeptidyl-peptidase IV inhibitor-associated bullous pemphigoid: A systematic review and meta-analysis. J Am Acad Dermatol. 2021;85(2):501-3.
  161. Kridin K. Accessible Diagnostic Methods to Differentiate between Epidermolysis Bullosa Acquisita and Other Subepidermal Autoimmune Bullous Diseases. Indian J Dermatol. 2018;63(5):445-8.
  162. Kridin K, Ludwig RJ. The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations. Front Med (Lausanne). 2018;5:220.
  163. Kridin K, Zamir H, Cohen AD. Cigarette smoking associates inversely with a cluster of two autoimmune diseases: ulcerative colitis and pemphigus. Immunol Res. 2018;66(4):555-6.
  164. Kridin K, Bergman R. Association of Bullous Pemphigoid With Dipeptidyl-Peptidase 4 Inhibitors in Patients With Diabetes: Estimating the Risk of the New Agents and Characterizing the Patients. JAMA Dermatol. 2018;154(10):1152-8.
  165. Amber KT, Valdebran M, Kridin K, Grando SA. The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease. Front Med (Lausanne). 2018;5:201.
  166. Kridin K, Shihade W, Bergman R. Mortality in Patients with Bullous Pemphigoid: A Retrospective Cohort Study, Systematic Review and Meta-analysis. Acta Derm Venereol. 2019;99(1):72-7.
  167. Kridin K, Schwartz N, Cohen AD, Zelber-Sagi S. Mortality in bullous pemphigoid: A systematic review and meta-analysis of standardized mortality ratios. J Dermatol. 2018;45(9):1094-100.
  168. Kridin K, Khamaisi M, Comaneshter D, Batat E, Cohen AD. Autoimmune Thyroid Diseases and Thyroid Cancer in Pemphigus: A Big Data Analysis. Front Med (Lausanne). 2018;5:159.
  169. Kridin K, Amber K, Khamaisi M, Comaneshter D, Batat E, Cohen AD. Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A population-based study. Immunol Res. 2018;66(3):425-30.
  170. Kridin K. Emerging treatment options for the management of pemphigus vulgaris. Ther Clin Risk Manag. 2018;14:757-78.
  171. Kridin K, Cohen AD, Amber KT. Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis. Am J Clin Dermatol. 2018;19(4):479-87.
  172. Kridin K, Comaneshter D, Batat E, Cohen AD. Pemphigus and smoking – insights from a big data analysis. J Eur Acad Dermatol Venereol. 2018;32(10):e384-e6.
  173. Kridin K, Comaneshter D, Cohen AD. Short article: Crohn's disease and pemphigus: is there an association?: a population-based study. Eur J Gastroenterol Hepatol. 2018;30(7):727-9.
  174. Kridin K. Peripheral eosinophilia in bullous pemphigoid: prevalence and influence on the clinical manifestation. Br J Dermatol. 2018;179(5):1141-7.
  175. Kridin K, Zelber-Sagi S, Bergman R. Risk factors for lethal outcome in patients with pemphigus: a retrospective cohort study. Eur J Dermatol. 2018;28(1):26-37.
  176. Kridin K, Comaneshter D, Batat E, Cohen AD. COPD and lung cancer in patients with pemphigus- a population based study. Respir Med. 2018;136:93-7.
  177. Kridin K. Pemphigus group: overview, epidemiology, mortality, and comorbidities. Immunol Res. 2018;66(2):255-70.
  178. Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD. Association Between Pemphigus and Neurologic Diseases. JAMA Dermatol. 2018;154(3):281-5.
  179. Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD. Coexistent Solid Malignancies in Pemphigus: A Population-Based Study. JAMA Dermatol. 2018;154(4):435-40.
  180. Kridin K, Zelber-Sagi S, Comaneshter D, Batat E, Cohen AD. Pemphigus and hematologic malignancies: A population-based study of 11,859 patients. J Am Acad Dermatol. 2018;78(6):1084-9 e1.
  181. Kridin K. Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations. Immunol Res. 2018;66(1):6-17.
  182. Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD. Association between pemphigus and psoriasis: A population-based large-scale study. J Am Acad Dermatol. 2017;77(6):1174-5.
  183. Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD. Bipolar Disorder Associated with Another Autoimmune Disease-Pemphigus: A Population-based Study. Can J Psychiatry. 2018;63(7):474-80.
  184. Kridin K, Bergman R. Ethnic variations in the epidemiology of bullous pemphigoid in Israel. Int J Dermatol. 2018;57(1):34-9.
  185. Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD. Ulcerative colitis associated with pemphigus: a population-based large-scale study. Scand J Gastroenterol. 2017;52(12):1360-4.
  186. Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD. Association between schizophrenia and an autoimmune bullous skin disease-pemphigus: a population-based large-scale study. Epidemiol Psychiatr Sci. 2019;28(2):191-8.
  187. Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD. Is there an association between pemphigus and hepatitis viruses? A population-based large-scale study. Immunol Res. 2017;65(5):1083-8.
  188. Kridin K, Bergman R. Association between bullous pemphigoid and psoriasis: A case-control study. J Am Acad Dermatol. 2017;77(2):370-2.
  189. Kridin K, Shihade W, Zelber-Sagi S. Mean Platelet Volume in Pemphigus Vulgaris. Angiology. 2018;69(4):303-7.
  190. Kridin K, Grifat R, Khamaisi M. Is there an ethnic variation in the epidemiology of gonorrhoea? A retrospective population-based study from northern Israel over 15 years between 2001 and 2015. BMJ Open. 2017;7(6):e014265.
  191. Kridin K, Zelber-Sagi S, Bergman R. Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality. Acta Derm Venereol. 2017;97(9):1095-9.
  192. Kridin K, Khamaisi M, Rishpon S, Grifat R. Striking ethnic variations in the epidemiology of Chlamydia trachomatis in Haifa District, Israel, throughout the years 2001-2015. Int J STD AIDS. 2017;28(14):1389-96.
  193. Kridin K, Sagi SZ, Bergman R. Mortality and Cause of Death in Patients with Pemphigus. Acta Derm Venereol. 2017;97(5):607-11.
  194. Kridin K, Zelber-Sagi S, Khamaisi M, Cohen AD, Bergman R. Remarkable differences in the epidemiology of pemphigus among two ethnic populations in the same geographic region. J Am Acad Dermatol. 2016;75(5):925-30.
  195. Kridin K, Bergman R, Khamaisi M, Zelber-Sagi S, Weltfriend S. Cement-Induced Chromate Occupational Allergic Contact Dermatitis. Dermatitis. 2016;27(4):208-14.
  196. Kridin K, Bergman R, Khamaisi M, Weltfriend S. Chromate Allergy in Northern Israel in Relation to Exposure to Cement and Detergents. Dermatitis. 2016;27(3):131-6.